Nuclear sphingolipid metabolism

Annual Review of Physiology

Volumn 74, Issue , 2012, Pages 131-151

  Lucki, Natasha C ^a   Sewer, Marion B ^b  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Ceramide; Ganglioside; Nucleus; Sphingomyelin; Sphingosine 1 phosphate

Indexed keywords

CERAMIDE; CERAMIDE 1 PHOSPHATE; CORTICOTROPIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; GANGLIOSIDE GD 1A; GANGLIOSIDE GD3; GANGLIOSIDE GM1; PHOSPHATIDYLCHOLINE; PHOSPHOLIPASE A2; PHOSPHOLIPASE D; RETINOIC ACID RECEPTOR; SPHINGOLIPID; SPHINGOMYELIN; SPHINGOSINE; SPHINGOSINE 1 PHOSPHATE;

ARTICLE; CALCIUM HOMEOSTASIS; CELL MEMBRANE; CELL NUCLEUS MATRIX; CELL NUCLEUS MEMBRANE; CELL PROLIFERATION; CHROMATIN; CHROMATIN ASSEMBLY AND DISASSEMBLY; DNA REPAIR; DNA REPLICATION; ENDOPLASMIC RETICULUM; GENE EXPRESSION; GENETIC REGULATION; GENETIC TRANSCRIPTION; HISTONE ACETYLATION; HUMAN; LIPID METABOLISM; LIPOGENESIS; NONHUMAN; NUCLEOLUS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RNA SPLICING; STEROIDOGENESIS; WESTERN BLOTTING;

ANIMALS; CALCIUM; CELL NUCLEUS; CERAMIDES; G(M1) GANGLIOSIDE; GANGLIOSIDES; HOMEOSTASIS; HUMANS; LYSOPHOSPHOLIPIDS; SPHINGOLIPIDS; SPHINGOMYELINS; SPHINGOSINE;

EID: 84856523320     PISSN: 00664278     EISSN: 15451585     Source Type: Book Series    
DOI: 10.1146/annurev-physiol-020911-153321     Document Type: Article

References (163)

1. Ledeen RW, Wu G. 2008. Nuclear sphingolipids: metabolism and signaling. J. Lipid Res. 49:1176-86
2. Ledeen RW, Wu G. 2006. Sphingolipids of the nucleus and their role in nuclear signaling. Biochim. Biophys. Acta 1761:588-98 (Pubitemid 43928867)
3. Tamiya-Koizumi K. 2002. Nuclear lipid metabolism and signaling. J. Biochem. 132:13-22 (Pubitemid 34832265)
4. Barlow CA, Laishram RS, Anderson RA. 2011. Nuclear phosphoinositides: a signaling enigma wrapped in a compartmental conundrum. Trends Cell Biol. 20:25-35
5. Albi E, Viola Magni M. 2004. The role of intranuclear lipids. Biol. Cell 96:657-67 (Pubitemid 39562238)
6. Krylova IN, Sablin EP, Moore J, Xu RX, Waitt GM, et al. 2005. Structural analyses reveal phosphatidyl inositols as ligands for the NR5 orphan receptors SF-1 and LRH-1. Cell 120:343-55 (Pubitemid 40222429)
7. Sablin EP, Blind RD, Krylova IN, Ingraham JG, Cai F, et al. 2009. Structure of SF-1 bound by different phospholipids: evidence for regulatory ligands. Mol. Endocrinol. 23:25-34
8. Irvine RF. 2003. Nuclear lipid signalling. Nat. Rev. Mol. Cell Biol. 4:349-60 (Pubitemid 36565567)
9. Pliss A, Kuzmin AN, Kachynski AV, Prasad PN. 2010. Nonlinear optical imaging and Ramanmicrospectrometry of the cell nucleus throughout the cell cycle. Biophys. J. 99:3483-91
10. Albi E, Mersel M, Leray C, Tomassoni ML, Viola-MagniMP. 1994. Rat liver chromatin phospholipids. Lipids 29:715-19 (Pubitemid 24321179)
11. Boronenkov IV, Loijens JC, Umeda M, Anderson RA. 1998. Phosphoinositide signaling pathways in nuclei are associated with nuclear speckles containing pre-mRNA processing factors. Mol. Biol. Cell 9:3547-60 (Pubitemid 28551047)
12. Neitcheva T, Peeva D. 1995. Phospholipid composition, phospholipase A2 and sphingomyelinase activities in rat liver nuclear membrane and matrix. Int. J. Biochem. Cell Biol. 27:995-1001
13. Xu A, Suh PG, Marmy-Conus N, Pearson RB, Seok OY, et al. 2001. Phosphorylation of nuclear phospholipase C β1 by extracellular signal-regulated kinase mediates the mitogenic action of insulin-like growth factor I. Mol. Cell. Biol. 21:2981-90 (Pubitemid 32298366)
14. Cocco L, Martelli AM, Gilmour RS, Ognibene A, Manzoli FA, Irvine RF. 1988. Rapid changes in phospholipid metabolism in the nuclei of Swiss 3T3 cells induced by treatment of the cells with insulinlike growth factor I. Biochem. Biophys. Res. Commun. 154:1266-72
15. Divecha N, Banfic H, Irvine RF. 1991. The polyphosphoinositide cycle exists in the nuclei of Swiss 3T3 cells under the control of a receptor (for IGF-I) in the plasma membrane, and stimulation of the cycle increases nuclear diacylglycerol and apparently induces translocation of protein kinase C to the nucleus. EMBO J. 10:3207-14 (Pubitemid 21905344)
16. Martelli AM, Gilmour RS, Neri LM, Manzoli L, Corps AN, Cocco L. 1991. Mitogen-stimulated events in nuclei of Swiss 3T3 cells. Evidence for a direct link between changes of inositol lipids, protein kinase C requirement and the onset of DNA synthesis. FEBS Lett. 283:243-46
17. Banfic H, Zizak M, Divecha N, Irvine RF. 1993. Nuclear diacylglycerol is increased during cell proliferation in vivo. Biochem. J. 290(Pt. 3):633-36 (Pubitemid 23100416)
18. Raben DM, Baldassare JJ. 2000. Nuclear envelope signaling: role of phospholipid metabolism. Eur. J. Histochem. 44:67-80 (Pubitemid 30301970)
19. Banno Y, Tamiya-Koizumi K, Oshima H, Morikawa A, Yoshida S, Nozawa Y. 1997. Nuclear ADPribosylation factor (ARF)- and oleate-dependent phospholipase D (PLD) in rat liver cells. Increases of ARF-dependent PLD activity in regenerating liver cells. J. Biol. Chem. 272:5208-13 (Pubitemid 27090080)
20. Manzoli FA, Capitani S, Mazzotti G, Barnabei O, Maraldi NM. 1982. Role of chromatin phospholipids on template availability and ultrastructure of isolated nuclei. Adv. Enzyme Regul. 20:247-62
21. Capitani S, Caramelli E, Felaco M, Miscia S, Manzoli FA. 1981. Effect of phospholipid vesicles on endogenous RNA polymerase activity of isolated rat liver nuclei. Physiol. Chem. Phys. 13:153-58
22. Li Y, Choi M, Cavey G, Daugherty J, Suino K, et al. 2005. Crystallographic identification and functional characterization of phospholipids as ligands for the orphan nuclear receptor steroidogenic factor-1. Mol. Cell 17:491-502 (Pubitemid 40269114)
23. Ortlund EA, Lee Y, Solomon IH, Hager JM, Safi R, et al. 2005. Modulation of human nuclear receptor LRH-1 activity by phospholipids and SHP. Nat. Struct. Biol. 12:357-63 (Pubitemid 43093091)
24. Wang W, Zhang C, Marimuthu A, Krupka HI, Tabrizizad M, et al. 2005. The crystal structures of human steroidogenic factor-1 and liver receptor homologue-1. Proc. Natl. Acad. Sci. USA 102:7505-10 (Pubitemid 40741001)
25. Martelli AM, Bortul R, Bareggi R, Manzoli L, Narducci, Cocco L. 2002. Diacylglycerol kinases in nuclear lipid-dependent signal transduction pathways. Cell Mol. Life Sci. 59:1129-37
26. Martelli AM, Fala F, Faenza I, Billi AM, Cappellini A, et al. 2004. Metabolism and signaling activities of nuclear lipids. Cell Mol. Life Sci. 61:1143-56 (Pubitemid 38703744)
27. Topham MK, Epand RM. 2009. Mammalian diacylglycerol kinases:molecular interactions and biological functions of selected isoforms. Biochim. Biophys. Acta 1790:416-24
28. Wattenberg BW, Pitson SM, Raben DM. 2006. The sphingosine and diacylglycerol kinase superfamily of signaling kinases: localization as a key to signaling function. J. Lipid Res. 47:1128-39 (Pubitemid 43830704)
29. Topham MK, Bunting M, Zimmerman GA, McIntyre TM, Blackshear PJ, Prescott SM. 1998. Protein kinase C regulates the nuclear localization of diacylglycerol kinase-γ. Nature 394:697-700 (Pubitemid 28389799)
30. Tabellini G, Bortul R, Santi S, Riccio M, Baldini G, et al. 2003. Diacylglycerol kinase-γ is localized in the speckle domains of the nucleus. Exp. Cell Res. 287:143-54 (Pubitemid 36683209)
31. Bregoli L, Baldassare JJ, Raben DM. 2001. Nuclear diacylglycerol kinase-γ is activated in response to α-thrombin. J. Biol. Chem. 276:23288-95
32. Tabellini G, Billi AM, Fala F, Cappellini A, Evagelisti C, et al. 2004. Nuclear diacylglycerol kinase-γis activated in response to nerve growth factor stimulation of PC12 cells. Cell Signal. 16:1263-71 (Pubitemid 39165454)
33. Li D, Urs AN, Allegood J, Leon A, Merrill AH Jr, Sewer MB. 2007. Cyclic AMP-stimulated interaction between steroidogenic factor 1 and diacylglycerol kinase ?facilitates induction of CYP17. Mol. Cell. Biol. 27:6669-85 (Pubitemid 47483621)
34. Ingraham HA, Lala DS, Ikeda Y, Luo X, Shen WH, et al. 1994. The nuclear receptor steroidogenic factor 1 acts at multiple levels of the reproductive axis. Genes Dev. 8:2302-12 (Pubitemid 24314292)
35. Parker KL, Rice DA, Lala DS, Ikeda Y, Luo X, et al. 2002. Steroidogenic factor 1: an essential mediator of endocrine development. Recent Prog. Horm. Res. 57:19-36
36. Csaki LS, Reue K. 2010. Lipins: multifunctional lipid metabolism proteins. Annu. Rev. Nutr. 30:257-72
37. Finck BN, Gropler MC, Chen Z, Leone TC, Croce MA, et al. 2006. Lipin 1 is an inducible amplifier of the hepatic PGC-1α/PPARαregulatory pathway. Cell Metab. 4:199-210 (Pubitemid 44283957)
38. Tsukahara T, Tsukahara R, Fujiwara Y, Yue J, Cheng Y, et al. 2010. Phospholipase D2-dependent inhibition of the nuclear hormone receptor PPAR?by cyclic phosphatidic acid. Mol. Cell 39:421-32
39. Strub GM, Maceyka M, Hait NC, Milstien S, Spiegel S. 2010. Extracellular and intracellular actions of sphingosine-1-phosphate. Adv. Exp. Med. Biol. 688:141-55
40. Hannun YA, Obeid LM. 2009. Principles of bioactive lipid signaling: lessons from sphingolipids. Nat. Rev. Mol. Cell Biol. 9:139-50 (Pubitemid 351158911)
41. Zeidan YH, Hannun YA. 2007. Translational aspects of sphingolipid metabolism. Trends Mol. Med. 13:327-36 (Pubitemid 47126985)
42. Tamiya-Koizumi K, Umekawa H, Yoshida S, Kojima K. 1989. Existence of Mg2+-dependent, neutral sphingomyelinase in nuclei of rat ascites hepatoma cells. J. Biochem. 106:593-98 (Pubitemid 19241827)
43. Alessenko A, Chatterjee S. 1995. Neutral sphingomyelinase: localization in rat liver nuclei and involvement in regeneration/proliferation. Mol. Cell. Biochem. 143:169-74
44. Wu G, Lu ZH, Ledeen RW. 1995. GM1ganglioside in the nuclear membrane modulates nuclear calcium homeostasis during neurite outgrowth. J. Neurochem. 65:1419-22
45. Micheli M, Albi E, Leray C, Magni MV. 1998. Nuclear sphingomyelin protectsRNAfromRNase action. FEBS Lett. 431:443-47
46. Tsugane K, Tamiya-Koizumi K, Nagino M, Nimura Y, Yoshida S. 1999. A possible role of nuclear ceramide and sphingosine in hepatocyte apoptosis in rat liver. J. Hepatol. 31:8-17 (Pubitemid 29287604)
47. Mizuno S, Nimura Y, Suzuki H, Yoshida S. 1996. Portal vein branch occlusion induces cell proliferation of cholestatic rat liver. J. Surg. Res. 60:249-57 (Pubitemid 26044326)
48. Xie X, Wu G, Lu ZH, Ledeen RW. 2002. Potentiation of a sodium-calcium exchanger in the nuclear envelope by nuclear GM1 ganglioside. J. Neurochem. 81:1185-95 (Pubitemid 34809253)
49. Rossi G, Magni MV, Albi E. 2007. Sphingomyelin-cholesterol and double stranded RNA relationship in the intranuclear complex. Arch. Biochem. Biophys. 459:27-32 (Pubitemid 46282600)
50. Albi E, Cataldi S, Rossi G, Viola Magni M, Toller M, et al. 2008. The nuclear ceramide/diacylglycerol balance depends on the physiological state of thyroid cells and changes during UV-C radiation-induced apoptosis. Arch. Biochem. Biophys. 478:52-58
51. Tempera I, Buchetti B, Lococo E, Gradini R, Mastronardi A, et al. 2008. GD3 nuclear localization after apoptosis induction in HUT-78 cells. Biochem. Biophys. Res. Commun. 368:495-500
52. Hait NC, Allegood J, Maceyka M, Strub GM, Harikumar KB, et al. 2009. Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate. Science 325:1254-57
53. Dupuy F, Fanani ML, Maggio B. 2011. Ceramide N-acyl chain length: a determinant of bidimensional transitions, condensed domain morphology, and interfacial thickness. Langmuir 27:3783-91
54. Stiban J, Fistere D, Colombini M. 2006. Dihydroceramide hinders ceramide channel formation: implications on apoptosis. Apoptosis 11:773-80 (Pubitemid 43876846)
55. Kotzerke J, Stibane C, Dralle H, Wiese H, BurchertW. 1989. Screening for pheochromocytoma in the MEN 2 syndrome. Henry Ford Hosp. Med. J. 37:129-31 (Pubitemid 20207547)
56. Farooqui AA, Horrocks LA. 2005. Signaling and interplay mediated by phospholipases A2, C, and D in LA-N-1 cell nuclei. Reprod. Nutr. Dev. 45:613-31 (Pubitemid 41511885)
57. Ondrias K, Lencesova L, Sirova M, Labudova M, Pastorekova S, et al. 2011. Apoptosis induced clustering of IP3R1 in nuclei of nondifferentiated PC12 cells. J. Cell. Physiol. 226:3147-55
58. Martelli AM, Manzoli L, Cocco L. 2004. Nuclear inositides: facts and persepectives. Pharmacol. Ther. 101:47-64
59. Cocco L, Martelli AM, Gilmour RS, Rhee SG, Manzolli FA. 2001. Nuclear phospholipase C and signaling. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1530:1-14 (Pubitemid 32121879)
60. 2+-independent phospholipase A2 in nuclei of LA-N-1 neuroblastoma cells. Neurochem. Res. 26:83-88 (Pubitemid 32428817)
61. Stiban J, Caputo L, Colombini M. 2008. Ceramide synthesis in the endoplasmic reticulum can permeabilize mitochondria to proapoptotic proteins. J. Lipid Res. 49:625-34
62. Rovina P, Schanzer A, Graf C, Mechtcheriakova D, Jaritz M, Bornancin F. 2009. Subcellular localization of ceramide kinase and ceramide kinase-like protein requires interplay of their Pleckstrin Homology domain-containing N-terminal regions together with C-terminal domains. Biochem. Biophys. Acta 1791:1023-30
63. 2+ signaling. Cell Signal. 21:440-47
64. Lamour N, Chalfant CE. 2008. Ceramide kinase and the ceramide-1- phosphate/cPLA2αinteraction as a therapeutic target. Curr. Drug Targets 9:674-82
65. Samanta S, Stiban J, Maugel TK, Colombini M. 2011. Visualization of ceramide channels by transmission electron microscopy. Biochim. Biophys. Acta 1808:1196-201
66. Cheng X, Blumenthal RM. 2010. Coordinated chromatin control: structural and functional linkage of DNA and histone methylation. Biochemistry 49:2999-3008
67. Lelievre SA. 2009. Contributions of extracellular matrix signaling and tissue architecture to nuclear mechanisms and spatial organization of gene expression control. Biochim. Biophys. Acta 1790:925-35
68. Lamond AI, Earnshaw WC. 1998. Structure and function in the nucleus. Science 280:547-53 (Pubitemid 28227750)
69. Mao C, Obeid LM. 2008. Ceramidases: regulators of cellular responses mediated by ceramide, sphingosine, and sphingosine-1-phosphate. Biochim. Biophys. Acta 1781:424-34
70. Pettus BJ, Chalfant CE, Hannun YA. 2002. Ceramide in apoptosis: an overview and current perspectives. Biochim. Biophys. Acta 1585:114-25 (Pubitemid 36092075)
71. Strelow A, Bernardo K, Adam-Klages S, Linke T, Sandhoff K, et al. 2000. Overexpression of acid ceramidase protects from tumor necrosis factor-induced cell death. J. Exp. Med. 192:601-12
72. Spiegel S, Milstien S. 2007. Functions of the multifaceted family of sphingosine kinases and some close relatives. J. Biol. Chem. 282:2125-29 (Pubitemid 47076736)
73. Takabe K, Paugh SW, Milstien S, Spiegel S. 2008. "Inside-out" signaling of sphingosine-1-phosphate: therapeutic targets. Pharmacol. Rev. 60:181-95 (Pubitemid 351962008)
74. Sukocheva O, Wang L, Verrier E, Vadas MA, Xia P. 2009. Restoring endocrine response in breast cancer cells by inhibition of the sphingosine kinase-1 signaling pathway. Endocrinology 150:4484-92
75. Takabe K, Kim RH, Allegood JC, Mitra P, Ramachandran S, et al. 2010. Estradiol induces export of sphingosine 1-phosphate from breast cancer cells via ABCC1 and ABCG2. J. Biol. Chem. 285:10477-86
76. Henkes LE, Sullivan BT, Lynch MP, Kolesnick R, Arsenault D, et al. 2008. Acid sphingomyelinase involvement in tumor necrosis factor α-regulated vascular and steroid disruption during luteolysis in vivo. Proc. Natl. Acad. Sci. USA 105:7670-75 (Pubitemid 351872696)
77. Kolesnick RN, Haimovitz-Friedman A, Fuks Z. 1994. The sphingomyelin signal transduction pathway mediates apoptosis for tumor necrosis factor, Fas, and ionizing radiation. Biochem. Cell Biol. 72:471-74
78. Watanabe M, Kitano T, Kondo T, Yabu T, Taguchi Y, et al. 2004. Increase of nuclear ceramide through caspase-3-dependent regulation of the "sphingomyelin cycle" in Fas-induced apoptosis. Cancer Res. 64:1000-7 (Pubitemid 38176903)
79. Nybond S, Bjorkqvist YJ, Ramstedt B, Slotte JP. 2005. Acyl chain length affects ceramide action on sterol/sphingomyelin-rich domains. Biochim. Biophys. Acta 1718:61-66 (Pubitemid 41698896)
80. Megha, Sawatzki P, Kolter T, Bittman R, London E. 2007. Effect of ceramide N-acyl chain and polar headgroup structure on the properties of ordered lipid domains (lipid rafts). Biochim. Biophys. Acta 1768:2205-12 (Pubitemid 47379609)
81. Senkal CE, Ponnusamy S, Bielawski J, Hannun YA, Ogretmen B. 2010. Antiapoptotic roles of ceramidesynthase- 6-generated C16-ceramide via selective regulation of the ATF6/CHOP arm of ER-stressresponse pathways. FASEB J. 24:296-308
82. Senkal CE, Ponnusamy S, Rossi MJ, Bialewski J, Sinha D, et al. 2007. Role of human longevity assurance gene 1 and C18-ceramide in chemotherapy-induced cell death in human head and neck squamous cell carcinomas. Mol. Cancer Ther. 6:712-22 (Pubitemid 46332472)
83. Mesicek J, Lee H, Feldman T, Jiang X, Skobeleva A, et al. 2010. Ceramide synthases 2, 5, and 6 confer distinct roles in radiation-induced apoptosis in HeLa cells. Cell Signal. 22:1300-7
84. Stiban J, Tidhar R, Futerman AH. 2010. Ceramide synthases: roles in cell physiology and signaling. Adv. Exp. Med. Biol. 688:60-71
85. Sun W, Jin J, Xu R, Hu W, Szulc ZM, et al. 2010. Substrate specificity, membrane topology, and activity regulation of human alkaline ceramidase 2 (ACER2). J. Biol. Chem. 285:8995-9007
86. Levy M, Futerman AH. 2010. Mammalian ceramide synthases. IUBMB Life 62:347-56
87. Gault CR, Obeid LM, Hannun YA. 2010. An overview of sphingolipid metabolism: from synthesis to breakdown. Adv. Exp. Med. Biol. 688:1-23
88. El Bawab S, Roddy P, Qian T, Bielawska A, Lemasters JJ, Hannun YA. 2000. Molecular cloning and characterization of a human mitochondrial ceramidase. J. Biol. Chem. 275:21508-13 (Pubitemid 30481855)
89. Hwang YH, Tani M, Nakagawa T, Okino N, Ito M. 2005. Subcellular localization of human neutral ceramidase expressed in HEK293 cells. Biochem. Biophys. Res. Commun. 331:37-42 (Pubitemid 40545138)
90. Breslow DK, Weissman JS. 2010. Membranes in balance: mechanisms of sphingolipid homeostasis. Mol. Cell 40:267-79
91. Mullen TD, Jenkins RW, Clarke CJ, Bielawski J, Hannun YA, Obeid LM. 2011. Ceramide synthasedependent ceramide generation and programmed cell death: involvement of salvage pathway in regulating post-mitochondrial events. J. Biol. Chem. 286:15929-42
92. 2+ loading capacity and promotes apoptosis. J. Biol. Chem. 286:4644-58
93. Mimeault M. 2002. New advances on structural and biological functions of ceramide in apoptotic/ necrotic cell death and cancer. FEBS Lett. 530:9-16 (Pubitemid 35248178)
94. Siskind LJ, Kolesnick RN, ColombiniM. 2006. Ceramide forms channels in mitochondrial outer membranes at physiologically relevant concentrations. Mitochondrion 6:118-25 (Pubitemid 43872021)
95. Grassme H, Jekle A, Riehle A, Schwarz H, Berger J, et al. 2001. CD95 signaling via ceramide-rich membrane rafts. J. Biol. Chem. 276:20589-96
96. Bollinger CR, Teichgraber V, Gulbins E. 2005. Ceramide-enriched membrane domains. Biochim. Biophys. Acta 1746:284-94 (Pubitemid 41815022)
97. Gupta S, Maurya MR, Merrill AH Jr, Glass CK, Subramaniam S. 2011. Integration of lipidomics and transcriptomics data towards a systems biology model of sphingolipid metabolism. BMC Syst. Biol. 5:26
98. Hornemann T, Penno A, Rutti MF, Ernst D, Kivrak-Pfiffner F, et al. 2009. The SPTLC3 subunit of serine palmitoyltransferase generates short chain sphingoid bases. J. Biol. Chem. 284:26322-30
99. Han G, Gupta SD, Gable K, Niranjanakumari S, Moitra P, et al. 2009. Identification of small subunits of mammalian serine palmitoyltransferase that confer distinct acyl-CoA substrate specificities. Proc. Natl. Acad. Sci. USA 106:8186-91
100. Eichler FS, Hornemann T, McCampbell A, Kuljis D, Penno A, et al. 2009. Overexpression of the wildtype SPT1 subunit lowers desoxysphingolipid levels and rescues the phenotype of HSAN1. J. Neurosci. 29:14646-51
101. Pruett ST, Bushnev A, Hagedorn K, Adiga M, Haynes CA, et al. 2008. Biodiversity of sphingoid bases ("sphingosines") and related amino alcohols. J. Lipid Res. 49:1621-39
102. Menaldino DS, Bushnev A, Sun A, Liotta DC, Symolon H, et al. 2003. Sphingoid bases and de novo ceramide synthesis: enzymes involved, pharmacology and mechanisms of action. Pharmacol. Res. 47:373-81 (Pubitemid 36379199)
103. Albi E, Cataldi S, Rossi G, Magni MV. 2003. A possible role of cholesterol-sphingomyelin/ phosphatidylcholine in nuclear matrix during rat liver regeneration. J. Hepatol. 38:623-28 (Pubitemid 36560647)
104. Albi E, Pieroni S, Viola Magni MP, Sartori C. 2003. Chromatin sphingomyelin changes in cell proliferation and/or apoptosis induced by ciprofibrate. J. Cell. Physiol. 196:354-61 (Pubitemid 36775883)
105. Ledeen RW, Wu G. 2006. Gangliosides of the nuclear membrane: a crucial locus of cytoprotective modulation. J. Cell Biochem. 97:893-903
106. Albi E, Cataldi S, Villani M, Perrella G. 2009. Nuclear phosphatidylcholine and sphingomyelin metabolism of thyroid cells changes during stratospheric balloon flight. J. Biomed. Biotechnol. 2009:125412
107. Albi E, La Porta CA, Cataldi S, Magni MV. 2005. Nuclear sphingomyelin-synthase and protein kinase C? in melanoma cells. Arch. Biochem. Biophys. 438:156-61 (Pubitemid 40798015)
108. Kleuser B, Maceyka M, Milstien S, Spiegel S. 2001. Stimulation of nuclear sphingosine kinase activity by platelet-derived growth factor. FEBS Lett. 503:85-90 (Pubitemid 32769961)
109. Cocco L, Maraldi NM, Manzoli FA, Gilmour RS, Lang A. 1980. Phospholipid interactions in rat liver nuclear matrix. Biochem. Biophys. Res. Commun. 96:890-98
110. Shiraishi T, Imai S, Uda Y. 2003. The presence of ceramidase activity in liver nuclear membrane. Biol. Pharm. Bull. 26:775-79 (Pubitemid 39655294)
111. Haines DS, Strauss KI, Gillespie DH. 1991. Cellular response to double-stranded RNA. J. Cell Biochem. 46:9-20
112. Albi E, Magni MP. 1997. Chromatin neutral sphingomyelinase and its role in hepatic regeneration. Biochem. Biophys. Res. Commun. 236:29-33 (Pubitemid 27341833)
113. Albi E, Magni MV. 1999. Sphingomyelin synthase in rat liver nuclear membrane and chromatin. FEBS Lett. 460:369-72 (Pubitemid 29495971)
114. Albi E, Lazzarini R, Magni MV. 2003. Reverse sphingomyelin-synthase in rat liver chromatin. FEBS Lett. 549:152-56 (Pubitemid 36959861)
115. Wang J, Wu G, Miyagi T, Lu ZH, Ledeen RW. 2009. Sialidase occurs in bothmembranes of the nuclear envelope and hydrolyzes endogenous GD1a. J. Neurochem. 111:547-54
116. Wu G, Lu ZH, Xie X, Ledeen RW. 2004. Susceptibility of cerebellar granule neurons from GM2/GD2 synthase-null mice to apoptosis induced by glutamate excitotoxicity and elevated KCl: rescue by GM1 and LIGA20. Glycoconj. J. 21:305-13 (Pubitemid 39434559)
117. James JL, Clawson GA, Chan CH, Smuckler EA. 1981. Analysis of the phospholipid of the nuclear envelope and endoplasmic reticulum of liver cells by high pressure liquid chromatography. Lipids 16:541-45
118. Keenan TW, Berezney R, Crane FL. 1972. Lipid composition of further purified bovine liver nuclear membranes. Lipids 7:212-15
119. Albi E, Magni MV. 2002. The presence and the role of chromatin cholesterol in rat liver regeneration. J. Hepatol. 36:395-400 (Pubitemid 34194800)
120. Lein M, Stibane I, Mansour R, Hege C, Roigas J, et al. 2006. Complications, urinary continence, and oncologic outcome of 1000 laparoscopic transperitoneal radical prostatectomies-experience at the Charite Hospital Berlin, Campus Mitte. Eur. Urol. 50:1278-82
121. Schmidt GW, Stibane H, Ulbrich F, Griesse H. 1967. Edwards syndrome with double trisomy D and E (mosaicism). Klin. Wochenschr. 45:634-38
122. Thevissen K, Francois IE, Winderickx J, Pannecouque C, Cammue BP. 2006. Ceramide involvement in apoptosis and apoptotic diseases. Mini. Rev. Med. Chem. 6:699-709 (Pubitemid 43881121)
123. Fasutino R, Cheung P, Richard M, Dibrov E, Kneesch A, et al. 2008. Ceramide regulation of nuclear protein import. J. Lipid Res. 49:654-62
124. Martelli AM, Evangelisti C, Nyakern M, Manzoli FA. 2006. Nuclear protein kinase C. Biochim. Biophys. Acta 1761:542-51 (Pubitemid 43928860)
125. Evangelisti C, Bortul R, Fala F, Tabellini G, Goto K, Martelli AM. 2007. Nuclear diacylglycerol kinases: emerging downstream regulators in cell signaling networks. Histol. Histopathol. 22:573-79 (Pubitemid 46647269)
126. Sun B, Murray NR, Fields AP. 1997. A role for nuclear phosphatidylinositol-specific phospholipase C in the G2/M phase transition. J. Biol. Chem. 272:26313-17 (Pubitemid 27458844)
127. Deacon EM, Pettitt TR, Webb P, Cross T, Chahal H, et al. 2002. Generation of diacylglycerolmolecular species through the cell cycle: a role for 1-stearoyl, 2-arachidonyl glycerol in the activation of nuclear protein kinase C-βII at G2/M. J. Cell Sci. 115:983-89 (Pubitemid 34257383)
128. Abboushi N, El-Hed A, El-Assaad W, Kozhaya L, El-Sabban ME, et al. 2004. Ceramide inhibits IL-2 production by preventing protein kinase C-dependent NF-κB activation: possible role in protein kinase C?regulation. J. Immunol. 173:3193-200 (Pubitemid 39142026)
129. Albi E, Micheli M, Viola Magni MP. 1996. Phospholipids and nuclear RNA. Cell Biol. Int. 20:407-12 (Pubitemid 26341192)
130. Chocian G, Chabowski A, Zendzian-Piotrowska M, Harasim E, Lukaszuk B, Gorski J. 2010. High fat diet induces ceramide and sphingomyelin formation in rats liver nuclei. Mol. Cell. Biochem. 340:125-31
131. Adams JM 2nd, Pratipanawatr T, Berria R, Wang E, DeFronzo RA, et al. 2004. Ceramide content is increased in skeletal muscle from obese insulin-resistant humans. Diabetes 53:25-31 (Pubitemid 38044694)
132. Chavez JA, Holland WL, Bar J, Sandhoff K, Summers SA. 2005. Acid ceramidase overexpression prevents the inhibitory effects of saturated fatty acids on insulin signaling. J. Biol. Chem. 280:20148-53 (Pubitemid 41379546)
133. Andreyev AY, Fahy E, Guan Z, Kelly S, Li X, et al. 2010. Subcellular organelle lipidomics in TLR-4- activated macrophages. J. Lipid Res. 51:2785-97
134. Schimazu T, Horinouchi S, Yoshida M. 2007. Multiple histone deacetylases and the CREB-binding protein regulate pre-mRNA 3prime;-end processing. J. Biol. Chem. 282:4470-78 (Pubitemid 47100930)
135. Pettus BJ, Bielawska A, Spiegel S, Roddy P, Hannun YA, Chalfant CE. 2003. Ceramide kinase mediates cytokine- and calcium ionophore-induced arachidonic acid release. J. Biol. Chem. 278:38206-13 (Pubitemid 37221709)
136. Lamour NF, Subramanian P, Wijesinghe DS, Stahelin RV, Bonventre JV, Chalfant CE. 2009. Ceramide 1-phosphate is required for the translocation of group IVA cytosolic phospholipase A2 and prostaglandin synthesis. J. Biol. Chem. 284:26897-907
137. Urs AN, Dammer E, Sewer M. 2006. Sphingosine regulates the transcription of CYP17 by binding to steroidogenic factor-1. Endocrinology 147:5249-58 (Pubitemid 44790580)
138. Sewer MB, Waterman MR. 2003. ACTH modulation of transcription factors responsible for steroid hydroxylase gene expression in the adrenal cortex. Microsc. Res. Tech. 61:300-7 (Pubitemid 36618456)
139. Sewer MB, Waterman MR. 2002. cAMP-dependent transcription of steroidogenic genes in the human adrenal cortex requires a dual-specificity phosphatase in addition to protein kinase A. J. Mol. Endocrinol. 29:163-74 (Pubitemid 34965754)
140. Maceyka M, Sankala H, Hait NC, Le Stunff H, Liu H, et al. 2005. SphK1 and SphK2, sphingosine kinase isoenzymes with opposing functions in sphingolipid metabolism. J. Biol. Chem. 280:37118-29 (Pubitemid 41587796)
141. Keenan TW, Morre DJ, Huang CM. 1972. Distribution of gangliosides among subcellular fractions from rat liver and bovine mammary gland. FEBS Lett. 24:204-8
142. Matyas GR, Morre DJ. 1987. Subcellular distribution and biosynthesis of rat liver gangliosides. Biochim. Biophys. Acta 921:599-614
143. Katoh N, Kira T, Yuasa A. 1993. Protein kinase C substrates and ganglioside inhibitors in bovine mammary nuclei. J. Dairy Sci. 76:3400-9
144. Wu G, Lu ZH, Ledeen RW. 1995. Induced and spontaneous neuritogenesis are associated with enhanced expression of ganglioside GM1 in the nuclear membrane. J. Neurosci. 15:3739-46
145. Saito M, Sugiyama K. 2002. Characterization of nuclear gangliosides in rat brain: concentration, composition, and developmental changes. Arch. Biochem. Biophys. 398:153-59 (Pubitemid 34848581)
146. Humbert JP, Matter N, Artault JC, Koppler P, Malviya AN. 1996. Inositol 1, 4, 5-trisphosphate receptor is located to the inner nuclear membrane vindicating regulation of nuclear calcium signaling by inositol 1, 4, 5-trisphosphate. Discrete distribution of inositol phosphate receptors to inner and outer nuclear membranes. J. Biol. Chem. 271:478-85
147. Gilchrist JS, Pierce GN. 1993. Identification and purification of a calcium-binding protein in hepatic nuclear membranes. J. Biol. Chem. 268:4291-99 (Pubitemid 23072970)
148. Saito M, Hagita H, Ito M, Ando S, Yu RK. 2002. Age-dependent reduction in sialidase activity of nuclear membranes from mouse brain. Exp. Gerontol. 37:937-41 (Pubitemid 34665485)
149. Wang J, Wu G, Miyagi T, Lu ZH, Ledeen RW. 2009. Sialidase occurs in bothmembranes of the nuclear envelope and hydrolyzes endogenous GD1a. J. Neurochem. 111:547-54
150. Parkinson ME, Smith CG, Garland PB, van Heyningen S. 1989. Identification of cholera toxin-binding sites in the nucleus of intestinal epithelial cells. FEBS Lett. 242:309-13 (Pubitemid 19020119)
151. Copani A, Melchiorri D, Caricasole A, Martini F, Sale P, et al. 2002. β-Amyloid-induced synthesis of the ganglioside GD3 is a requisite for cell cycle reactivation and apoptosis in neurons. J. Neurosci. 22:3963-68 (Pubitemid 37465704)
152. Philipson KD, Nicoll DA. 2000. Sodium-calcium exchange: a molecular perspective. Annu. Rev. Physiol. 62:111-33 (Pubitemid 30618258)
153. Xie X, Wu G, Lu ZH, Rohowsky-Kochan C, Ledeen RW. 2004. Presence of sodium-calcium exchanger/ GM1 complex in the nuclear envelope of non-neural cells: nature of exchanger-GM1 interaction. Neurochem. Res. 29:2135-46 (Pubitemid 39663892)
154. Ledeen R, Wu G. 2011. New findings on nuclear gangliosides: overview on metabolism and function. J. Neurochem. 116:714-20
155. Kofuji P, Lederer WJ, Schulze DH. 1994. Mutually exclusive and cassette exons underlie alternatively spliced isoforms of the Na/Ca exchanger. J. Biol. Chem. 269:5145-49 (Pubitemid 24239505)
156. 2+ exchanger in rat astrocytes and neurons by PKA. J. Neurosci. 18:4833-41 (Pubitemid 28285392)
157. Wu G, Xie X, Lu ZH, Ledeen RW. 2009. Sodium-calcium exchanger complexed with GM1 ganglioside in nuclear membrane transfers calcium from nucleoplasm to endoplasmic reticulum. Proc. Natl. Acad. Sci. USA 106:10829-34
158. Xie X, Wu G, Ledeen RW. 2004. C6 cells express a sodium-calcium exchanger/GM1 complex in the nuclear envelope but have no exchanger in the plasma membrane: comparison to astrocytes. J. Neurosci. Res. 76:363-75 (Pubitemid 38580131)
159. Wu G, Lu ZH, Kulkarni N, Amin R, Ledeen RW. 2011. Mice lacking major brain gangliosides develop Parkinsonism. Neurochem. Res. 36:1706-14
160. Ledeen R, Wu G. 2011. New findings on nuclear gangliosides: overview on metabolism and function. J. Neurochem. 116:714-20
161. Liu Y, Wada R, Kawai H, Sango K, Deng C, et al. 1999. A genetic model of substrate deprivation therapy for a glycosphingolipid storage disorder. J. Clin.
162. Wu G, Xie X, Lu ZH, Ledeen RW. 2001. Cerebellar neurons lacking complex gangliosides degenerate in the presence of depolarizing levels of potassium. Proc. Natl. Acad. Sci. USA 98:307-12 (Pubitemid 32095905)
163. Fujiwara Y. 2008. Cyclic phosphatidic acid-a unique phospholipid. Biochim. Biophys. Acta 1781(9):519-24